Prednylidene
From Wikipedia, the free encyclopedia
|
Prednylidene
|
|
| Systematic (IUPAC) name | |
| (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | H02 |
| PubChem | |
| Chemical data | |
| Formula | C22H28 |
| Mol. mass | 372.455 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Prednylidene is a glucocorticoid for systemic use.
|
|||||||||||

